MELISSA LIM: Open Payments
NPI 1962288464 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 18 payments from 10 companies in 2025. Trend: 2023 $98 · 2024 $2,425 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $158 |
| LEO Pharma Inc. | 2 | $53 |
| UCB, Inc. | 2 | $50 |
| Amgen Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| PFIZER INC. | 1 | $15 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: DUPIXENT, ADBRY, Bimzelx, OTEZLA, COSENTYX, TALTZ, SKYRIZI, CIBINQO.
Industry payments across AZ — which companies pay providers there.
